EditorialSharif Tabebordbar of the Broad Institute at the Massachusetts Institute of Technology in Cambridge, Mass., at the school on Sept. 15, 2021. (Simon Simard/The New York Times)
EditorialSharif Tabebordbar of the Broad Institute at the Massachusetts Institute of Technology in Cambridge, Mass., at the school on Sept. 15, 2021. (Simon Simard/The New York Times)
EditorialQiana Mosely, who lost 40 pounds while participating in a clinical trial of the drug semaglutide, in Chicago, Feb. 10, 2021. (Taylor Glascock/The New York Times)